Pedinol Pharmacal Inc. Announces Health Advisory for Gris-PEG (griseofulvin ultramicrosize) 125mg and 250mg

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Pedinol Pharmacal Inc. Announces Health Advisory for Gris-PEG (griseofulvin ultramicrosize) 125mg and 250mg

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Pedinol Pharmacal Inc. Announces Health Advisory for Gris-PEG (griseofulvin ultramicrosize) 125mg and 250mg

02/03/2012 01:02 PM EST

Pedinol Pharmacal Inc. today announced that it is advising healthcare professionals, pharmacists and patients of a potential problem with Gris-PEG (griseofulvin ultramicrosize) 125mg and 250mg manufactured and packaged by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420